Cell-Penetrating Peptide Enhances Tafazzin Gene Therapy in Mouse Model of Barth Syndrome.
Saved in:
| Title: | Cell-Penetrating Peptide Enhances Tafazzin Gene Therapy in Mouse Model of Barth Syndrome. |
|---|---|
| Authors: | Raghav R; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA., Awata J; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA., Martin GL; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA., Strathdee D; Cancer Research UK Beatson Institute, Glasgow G61 1BD, UK., Blanton RM; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA., Chin MT; Molecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA. |
| Source: | International journal of molecular sciences [Int J Mol Sci] 2024 Dec 18; Vol. 25 (24). Date of Electronic Publication: 2024 Dec 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
